// App-Quantinova.ai

: Long-Term Follow-up of AML Patients Treated Intensively before the Era of Targeted Agents. a Big Data Analysis from the Harmony Collaboration

Researchers

Presenter

  • Marta Anna Sobas

Principal Investigators

  • Alberto Hernández Sánchez

  • Javier Martinez Elicegui

  • Teresa Gonzalez

  • Raúl Azibeiro Melchor

  • Maria Abaigar

  • Laura Tur

  • Daniele Dall'Olio

  • Eric Sträng

  • Jesse M. Tettero

  • Castellani Gastone

  • Axel Benner

  • Konstanze Dohner

  • Christian Thiede

  • Amin T. Turki

  • Klaus H. Metzeler

  • Torsten Haferlach

  • Frederick Damm

  • Rosa Ayala

  • Joaquin Martinez-Lopez

  • Ken I Mills

  • Jorge Sierra

  • Soren Lehmann

  • Matteo G. Della Porta

  • Jiri Mayer

  • Dirk Reinhardt

  • Rubén Villoria Medina

  • Renate Schulze-Rath

  • Martje Barbus

  • Jesus Maria Hernandez-Rivas

  • Brian James Patrick Huntly

  • Gert Ossenkoppele

  • Hartmut Dohner

  • Lars Bullinger

Medical Centers

  • MLL Munich Leukemia Laboratory, Munich, Germany

  • Department of Pediatrics III, University Hospital Essen, University Duisburg-Essen, Essen, Germany

  • Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany

  • Hematology and Oncology, University Hospital Brno, Czech Republic, Brno, Czech Republic

  • Department of Internal Medicine I, University Hospital Dresden, Dresden, Germany

  • Department of Hematology and Stem Cell Transplantation, University Hospital of Essen, Essen, Germany

  • UNIVERSITY OF BOLOGNA, Bologna, Italy

  • Vrye Universiteit Academic Medical Center, Amsterdam, NLD

  • Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, United Kingdom

  • Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine Berlin, Berlin, Germany

  • Department of Experimental, Diagnostic and Specialty Medicine - DIMES, University of Bologna, Bologna, Italy

  • Cancer Center, IRCCS Humanitas Research Hospital & Humanitas University, Rozzano, Italy

  • Division of Hematology and Oncology, University Hospital Ulm, Ulm, Germany

  • Department for Hematology, Cell Therapy and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany

  • Hematology Department, University Hospital of Salamanca, Salamanca, Spain

  • Department of Hematology, Amsterdam University Medical Center location Vrije Universiteit Amsterdam, Amsterdam, Netherlands

  • Unidad de Diagnóstico Molecular y Celular del Cáncer, Centro de Investigación del Cáncer-Universidad de Salamanca (IBMCC, USAL-CSIC); Genética Molecular en Oncohematología, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain

  • Uppsala University Hospital, Uppsala, Sweden

  • Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain

  • Molecular Genetics in Oncohematology, Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain

  • Department of Hematology, Oncology and Tumorimmunology (Campus Virchow-Klinikum), Charite University Berlin, Berlin, Germany

  • Internal Medicine III, University of Ulm, Ulm, Germany

  • Department of Hematology, Blood Neoplasm and Bone Marrow Transplantation, Hosp. Clinico Univ. de Santiago de Compostela, Santiago de Compostela, Spain

  • Hospital Universitario de Burgos, Burgos, Spain

  • Hospital Santa Creu Sant Pau, Barcelona, Spain

  • Hematology Department, Hospital Universitario de Octubre, CNIO, Complutense University, Madrid, Spain

  • Hospital Universitario de Octubre, Madrid, Spain

  • Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom

Locations

  • Germany

  • United States

  • Spain

  • United Kingdom

  • Netherlands

  • Czech Republic

  • Sweden

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute promyelocytic leukemia

Biomarkers

  • Estrogen receptor alpha

Drug/Treatment

  • Vidaza

  • Cytarabine liposomal

Outcome

  • N/A

Study Design

  • Observational

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved